SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wharf Rat who wrote (1212345)3/24/2020 1:34:09 AM
From: Winfastorlose1 Recommendation

Recommended By
FJB

  Read Replies (4) of 1577123
 
Yes it is. The FDA panels that approve drugs for big pharma are often gutted after approval due to the panel members taking high paying jobs with the companies whose drugs they just reviewed. Many effective drugs are left on the table until the companies that own them take a more influential partner. It's like a mafia.

You want a drug with efficacy? Go to Israel. You can get what you need to survive there. Here in the US? Not so much.

You don't know squat about this issue. I have been involved in it for many years through my work in the securities industry. . But like with everything else, you think you know but you really don't know much at all.

Like I have told you many times, Berkeley owes you a refund.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News